| |
|
|
|
|
|
|
|||
|
Blood, 15 October 2005, Vol. 106, No. 8, pp. 2655-2662. Prepublished online as a Blood First Edition Paper on June 30, 2005; DOI 10.1182/blood-2005-01-0028.
Submitted January 5, 2005
Department of Pathology, Jefferson Medical College, Philadelphia, PA, USA * Corresponding author; email: david.strayer{at}jefferson.edu.
Hematopoietic stem cell (HSC) gene transfer has been attempted almost entirely ex vivo, and has been limited by cytokine-induced loss of self-renewal capacity and transplantation-related defects in homing and engraftment. Here, we attempted to circumvent such limitations by injecting vectors directly into the bone marrow (BM), to transduce HSC in their native environment. SV40-derived gene delivery vectors were used because they transduce resting CD34+ cells very efficiently. Rats received SV(Nef-FLAG), carrying FLAG marker epitope, or a control rSV40, directly into both femoral marrow cavities. Intracellular transgene expression by PB or BM cells was detected by cytofluorimetry. An average of 5.3% of PB leukocytes expressed FLAG for the entire study, 56 weeks. Transgene expression was sustained in multiple cell lineages, including granulocytes (average, 3.3% of leukocytes, 20.4% of granulocytes), CD3+ T lymphocytes (average, 0.53% of leukocytes, 1% of total T cells) and CD45R+ B lymphocytes, indicating gene transfer to long-lived progenitor cells with multilineage capacity. An average of 15% of femoral marrow cells expressed FLAG up to 16.5 months post-transduction. Thus, direct intramarrow administration of rSV40s yields efficient gene transfer to rat BM progenitor cells, and may be worthy of further investigation.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2005 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||